Infinium Pharmachem Limited (NSE:INFINIUM)
India · Delayed Price · Currency is INR 252.00
+4.25 (1.72%)
At close: Oct 15, 2025
Infinium Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
Operating Revenue | 1,557 | 1,357 | 1,142 | 991.19 | 545.58 | Upgrade |
Other Revenue | - | - | - | - | 2.01 | Upgrade |
| 1,557 | 1,357 | 1,142 | 991.19 | 547.59 | Upgrade | |
Revenue Growth (YoY) | 14.78% | 18.77% | 15.24% | 81.01% | 50.32% | Upgrade |
Cost of Revenue | 1,178 | 1,040 | 810.2 | 769.18 | 397.69 | Upgrade |
Gross Profit | 378.89 | 316.45 | 332.05 | 222.01 | 149.9 | Upgrade |
Selling, General & Admin | 87.88 | 65.86 | 57.95 | 38.23 | 23.79 | Upgrade |
Other Operating Expenses | 125.37 | 65.02 | 113.54 | 82.27 | 74.59 | Upgrade |
Operating Expenses | 246.19 | 157.56 | 184.88 | 127.88 | 104.89 | Upgrade |
Operating Income | 132.7 | 158.89 | 147.16 | 94.13 | 45.01 | Upgrade |
Interest Expense | -24.93 | -18.53 | -27.94 | -14.4 | -9.16 | Upgrade |
Interest & Investment Income | 0.89 | 1.82 | 0.2 | 0.3 | 0.18 | Upgrade |
Currency Exchange Gain (Loss) | 9.7 | 6.87 | 9.97 | 2.08 | 3.63 | Upgrade |
Other Non Operating Income (Expenses) | -2.65 | 3.06 | 0.15 | 4.21 | -2.08 | Upgrade |
EBT Excluding Unusual Items | 115.7 | 152.1 | 129.53 | 86.32 | 37.58 | Upgrade |
Pretax Income | 115.7 | 152.1 | 129.53 | 86.32 | 37.58 | Upgrade |
Income Tax Expense | 37.27 | 37.07 | 31.36 | 19.47 | 10.39 | Upgrade |
Earnings From Continuing Operations | 78.43 | 115.03 | 98.17 | 66.86 | 27.19 | Upgrade |
Minority Interest in Earnings | 3.02 | -2.01 | -3.27 | -5.79 | - | Upgrade |
Net Income | 81.45 | 113.02 | 94.9 | 61.06 | 27.19 | Upgrade |
Net Income to Common | 81.45 | 113.02 | 94.9 | 61.06 | 27.19 | Upgrade |
Net Income Growth | -27.93% | 19.10% | 55.41% | 124.55% | 167.10% | Upgrade |
Shares Outstanding (Basic) | 15 | 11 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 15 | 11 | 10 | 10 | 10 | Upgrade |
Shares Change (YoY) | 36.49% | 4.80% | - | - | - | Upgrade |
EPS (Basic) | 5.60 | 10.61 | 9.33 | 6.01 | 2.67 | Upgrade |
EPS (Diluted) | 5.60 | 10.61 | 9.33 | 6.01 | 2.67 | Upgrade |
EPS Growth | -47.21% | 13.64% | 55.41% | 124.55% | 167.23% | Upgrade |
Free Cash Flow | -343.76 | 14.06 | 11.23 | 70.69 | 22.11 | Upgrade |
Free Cash Flow Per Share | -23.64 | 1.32 | 1.10 | 6.95 | 2.17 | Upgrade |
Gross Margin | 24.33% | 23.33% | 29.07% | 22.40% | 27.37% | Upgrade |
Operating Margin | 8.52% | 11.71% | 12.88% | 9.50% | 8.22% | Upgrade |
Profit Margin | 5.23% | 8.33% | 8.31% | 6.16% | 4.97% | Upgrade |
Free Cash Flow Margin | -22.08% | 1.04% | 0.98% | 7.13% | 4.04% | Upgrade |
EBITDA | 165.64 | 185.57 | 160.55 | 100.44 | 51.52 | Upgrade |
EBITDA Margin | 10.64% | 13.68% | 14.06% | 10.13% | 9.41% | Upgrade |
D&A For EBITDA | 32.95 | 26.68 | 13.39 | 6.31 | 6.51 | Upgrade |
EBIT | 132.7 | 158.89 | 147.16 | 94.13 | 45.01 | Upgrade |
EBIT Margin | 8.52% | 11.71% | 12.88% | 9.50% | 8.22% | Upgrade |
Effective Tax Rate | 32.21% | 24.37% | 24.21% | 22.55% | 27.64% | Upgrade |
Revenue as Reported | 1,578 | 1,372 | 1,156 | 1,001 | 551.81 | Upgrade |
Advertising Expenses | 13.59 | 6.75 | 4.24 | 2.83 | 1.68 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.